Tootfinder

U.S. health advisers are debating a new kind of flu vaccine Thursday,
the first made with the same mRNA technologythat was key to ending the COVID-19 pandemic.
Moderna is seeking Food and Drug Administration approval of its new shot, dubbed #mFlusiva,
as an option for people 50 and older.
The FDA advisory committee meeting is a step toward a final decision ahead of the winter flu se…

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
U.S. health advisers are debating a new kind of flu vaccine